Aenova
Pharmaceutical ManufacturingGermany, Germany5001-10000 Employees
Aenova’s contract development and manufacturing services cover the entire value chain from the development to commercial production of all common dosage forms in pharmaceuticals and dietary supplements for human and animal health products. With a turnover of approximately 750 million Euros, the Aenova Group is a leading CDMO worldwide and the number #1 choice in Europe. Our significant multinational investment in development and manufacturing capacity has also resulted in new technologies and innovations to meet your evolving product requirements. Our focus on high quality standards, time-to-market requirements, and experience makes Aenova the partner of choice for contract development and manufacturing.